Edition:
United States

Medtronic PLC (MDT.N)

MDT.N on New York Stock Exchange

72.11USD
6 Dec 2016
Change (% chg)

$0.44 (+0.61%)
Prev Close
$71.67
Open
$72.06
Day's High
$72.43
Day's Low
$71.58
Volume
1,512,472
Avg. Vol
1,475,385
52-wk High
$89.27
52-wk Low
$71.03

Select another date:

Tue, Nov 29 2016

BRIEF-Medtronic announces U.S. launch of integrated health solutions

* Medtronic announces U.S. launch of integrated health solutions with university hospitals agreement Source text for Eikon: Further company coverage:

BRIEF-Medtronic first to receive european approval for less-invasive HVAD implant procedure

* Medtronic first to receive european approval for less-invasive HVAD implant procedure Source text for Eikon: Further company coverage:

BRIEF-Medibio enters into binding agreement with Medtronic

* Asx alert-medibio enters into binding agreement with medtronic-meb.ax

Medtronic sales disappoint, firm lowers forecast; shares fall

Medtronic Plc on Tuesday reported quarterly sales below Wall Street's expectations for virtually all its major product lines and cut its full-year earnings forecast, and the medical device maker's shares fell more than 8 percent.

UPDATE 4-Medtronic sales disappoint, firm lowers forecast; shares fall

Nov 22 Medtronic Plc on Tuesday reported quarterly sales below Wall Street's expectations for virtually all its major product lines and cut its full-year earnings forecast, and the medical device maker's shares fell more than 8 percent.

BRIEF-Medtronic CEO says disappointed by Q2, but headwinds are largely temporary: Conf Call

* Medtronic CEO says he expects pressures in CRHF (part of Medtronic's heart division) to continue through the fiscal year

Medtronic's quarterly revenue rises 4 pct

Nov 22 Medtronic Plc, the world's largest standalone medical device maker, reported a 4 percent rise in quarterly revenue, helped by higher demand for its minimally invasive devices and heart products.

BRIEF-Medtronic Q2 non-GAAP earnings per share $1.12

* Company reported Q2 worldwide revenue of $7.345 billion, an increase of 4 percent, or 3 percent on a constant currency basis

BRIEF-Medtronic says data demonstrates Heli-FX EndoAnchor system enhances outcomes, durability in patients

* Medtronic says data demonstrates Heli-FX EndoAnchor system enhances outcomes,durability in patients with complex aortic abdominal aneurysm (AAA) anatomy

BRIEF-Medtronic's Solitaire Device gets expanded indication from U.S. FDA

* Medtronic's Solitaire(TM) stent retriever device receives expanded indication from the U.S. Food and drug administration for the reduction of stroke-related disability Source text for Eikon: Further company coverage:

Select another date: